Definitive Contract 75N93026C00003
Award Date 4/1/26
Potential Completion Date 3/31/33
Potential Value $33M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Frederick, MD 21703, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $6,101,446.00 definitive contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Eminent Services Corp, a small business, for a Clinical Products Distribution Center. The contract has a cost plus fixed fee pricing structure and a period of performance through September 2, 2015. Eminent Services Corp is a minority-owned business that provides pharmaceutical, biological, and information technology services to the...
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), to The Emmes Company LLC, a for-profit limited liability company. The $229,401 contract is for NIAID's Comprehensive and Rapid Response for NIAID Research Programs (CARRRP) initiative, supporting clinical trials and research related to infectious diseases. The contract is a cost-plus-fixed-fee arrangement and does not have a...
- This is a $86,434,294.97 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Fisher BioServices Inc., a subsidiary of Thermo Electron Corporation. The contract is for the continuation of the Clinical Research Products Management Center (CRPMC), which provides pharmaceutical services and study product management expertise for over 80 HIV/AIDS and related clinical trials annually...
- The National Institute of Allergy and Infectious Diseases awarded a $29.1 million definitive contract to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific, on November 1, 2021, for the Regulatory Management Center program. The contract, which extends through October 31, 2028, is structured as a cost-plus-fixed-fee arrangement with no set-aside designation, reflecting PPD's status as a large business capable of competing for unrestricted...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $21.6 million to PPD Development LP for Division of AIDS (DAIDS) monitoring services supporting the Phase III PHOENIX study (A5300B/I2003B). This contract, awarded December 15, 2025, with an ultimate completion date of December 14, 2028, will be performed in Cape Fear, North Carolina. The award utilizes a cost-plus-fixed-fee pricing structure with no set-aside designation and represents a child...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $49,946.10 firm-fixed-price purchase order contract for antibody expression services to Biointron Biological USA Inc., a small disadvantaged business. The contract, which has no set-aside designation, has an ultimate completion date of July 11, 2025. The award was made on July 12, 2024. NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious and...
- The National Institute of Allergy and Infectious Diseases awarded a $1.86 million cost-plus-fixed-fee task order (75N93022F00001) to PPD Development LP for administration and overall clinical operations support and concept development under the Early Phase Clinical Trial Units (EPCTU) indefinite delivery/indefinite quantity contract. The task order, issued on January 14, 2022, with an ultimate completion date of January 13, 2032, represents the base award for clinical trial management and...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Emmes Company LLC, a for-profit limited liability company. The $26,698,456.17 cost-plus-fixed-fee contract is a delivery order with a completion date of July 31, 2022. It is not a set-aside contract. The Emmes Company LLC is an experienced provider of comprehensive research support services to federal agencies, particularly the National Institutes of Health (NIH)....
- The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, awarded a delivery order contract to Digital Infuzion, LLC, a minority-owned small business based in Rockville, Maryland, for Clinical Research Management System (CRMS) Support Services. The contract, awarded on September 26, 2023, carries a ceiling value of $111.0 million and extends through September 25, 2028. Structured as a time-and-materials delivery order under the General...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order contract to Medical Science & Computing, LLC for professional, technical, and scientific support services to the Division of Intramural Research (DIR) and the Office of Intramural Research (OIR). The contract, with a ceiling value of $47,685.75, was awarded on February 11, 2020, with an ultimate completion date of February 10, 2023. This firm-fixed-price delivery order was issued without a set-aside...